La vendita allo scoperto per Webuy Global dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Webuy Global. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Webuy Global (NASDAQ:WBUY) Azioni, Report sulle vendite allo scoperto

Webuy Global Ltd is an emerging Southeast Asian (SEA) community-oriented e-commerce retailer (Community e-Commerce Retailer) with a focus on grocery and travel. Community e-commerce is a deepened extension form of e-commerce, where social media users with mutual interest and like-minded behavior are connected, forming a community group within a network through an online medium. Its mission is to make social shopping a new lifestyle for consumers and to empower consumers' purchases with an efficient, cost-saving purchasing model. The company is also engaged in selling packaged tours to its customers. The majority of revenue is derived from the sales of groceries through its online platform. Its geographic areas are Singapore, Indonesia, and Malaysia.

Macro Economic Events

News

Politics

Economics

General

TSLA

Live On CNBC, Treasury Secretary Scott Bessent, On Elon Musk, Says I Have Great Respect For Elon On Rockets, He Can Leave Finances To Me

A devastating house fire taught one financial expert a hard lesson about insurance: having a policy is not the same as being prepared. In a <a href="https://www.forbes.com/sites/janetarzt/2025/06/16/when-life-hits-hard-heres-what-women-need-to-know-about-insurance/">Forbes</a> column, Parere Advisory founder Janet Arzt wrote that the claims process was confusing, overwhelming, and time-consuming, despite having homeowners&#8217; insurance.
Arzt urged women to better understand insurance's role in financial planning, particularly as they increasingly manage household and generational wealth.
<h2 class="wp-block-heading">The Insurance Gap Women Face</h2>
Arzt noted that women live longer than men on average and tend to have lower retirement savings. According to Deloitte's 2024 insurance consumer <a href="https://www.deloitte.com/us/en/insights/industry/financial-services/bridging-the-gap-between-homeowners-insurance-companies-climate-change.html">survey</a>, many insured individuals are unclear on what coverage they need and how much to purchase, putting them at risk of inadequate compensation after a loss.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
Data from the Life Insurance Marketing and Research Association <a href="https://www.limra.com/siteassets/newsroom/liam/2023/0859-2023-liam-fact-sheet-2023_final.pdf">shows</a> women are often underinsured when it comes to life insurance, a gap attributed to income disparities and limited access to financial education. According to the <a href="https://sites.utexas.edu/contemporaryfamilies/2021/11/02/breadwinning-mothers-brief-report/">Council of Contemporary Families</a>, about 70% of mothers can expect to be primary financial earners before their children turn 18, with an average span of six years. Women are the primary drivers of consumer spending and control $11 trillion in assets—a figure expected to rise to $30 trillion by 2030, according to <a href="https://www.mckinsey.com/featured-insights/sustainable-inclusive-growth/charts/women-control-only-a-third-of-household-financial-assets-in-the-united-states-for-now">McKinsey</a>.
<h2 class="wp-block-heading">Understanding Life and Non-Life Coverage</h2>
Arzt emphasized that insurance typically falls into two categories: life and non-life. Life insurance—especially permanent policies—can be used for tax-advantaged wealth transfers, charitable giving, or securing business continuity for primary earners. This could be relevant to the 70% of women expected to inherit a large share of the<a href="https://www.cerulli.com/press-releases/cerulli-anticipates-124-trillion-in-wealth-will-transfer-through-2048"> $124 trillion</a> in intergenerational wealth transfers projected by 2048, according to a <a href="https://institute.bankofamerica.com/content/dam/economic-insights/women-and-wealth-creating-opportunities.pdf">study</a> by the Bank of America Institute.
Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a><a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning"> </a>&nbsp;
Non-life insurance, including property, disability, and long-term care coverage, is equally critical. A 2024 Commonwealth Fund <a href="https://www.commonwealthfund.org/publications/surveys/2024/nov/state-health-insurance-coverage-us-2024-biennial-survey">survey</a> reported that 23% of American adults are underinsured for health needs, despite many having employer-sponsored plans. A 2025 <a href="https://nationalpartnership.org/news_post/unpaid-caregiving-valued-at-more-than-1-trillion-per-new-analysis/">analysis</a> by the National Partnership for Women &amp; Families found that women perform two-thirds of unpaid caregiving in the U.S., spending an average of 300 hours annually on caregiving tasks — a contribution valued at $683 billion nationally. This disproportionate caregiving burden further increases women's need for long-term care and income protection coverage.
<h2 class="wp-block-heading">Advocate, Audit, and Prepare</h2>
Arzt wrote in Forbes that her biggest challenge after the fire was navigating complex policy documents and claims terms without sufficient support. She recommended hiring an independent agent, insurance attorney, or financial advisor to conduct an audit of existing policies and flag potential coverage gaps.
Arzt also pointed to the role of nonprofit and advocacy groups such as United Policyholders and the Red Cross for assistance during disaster recovery. Still, she emphasized in her Forbes column that women must act as their own primary advocates—reading all policy details, asking questions, and ensuring coverage plans are aligned with their life circumstances.
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Practical Steps to Take</h2>
Arzt recommended that individuals create and maintain an annual home inventory with photos, serial numbers, receipts, and timestamps. Store documentation securely—ideally in both physical and cloud formats—and photograph damages before initiating repairs after any loss event.
Though reviewing insurance plans may not be a daily priority, Arzt wrote in Forbes that it is an essential part of long-term wealth protection. "Understanding how insurance plays a role in wealth planning can also increase your confidence in financial decision-making and reduce any anxieties about the future," she said.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

After Losing Everything In A Fire, This Financial Expert Shares Insurance Lessons Women Should Know

A fully independent company, Fresh Del Monte is unaffected by the recent legal and financial matters involving Del Monte Foods Inc.
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.freshdelmonte.com%2F&amp;esheet=54285663&amp;newsitemid=20250703233115&amp;lan=en-US&amp;anchor=Fresh+Del+Monte+Produce+Inc.&amp;index=1&amp;md5=ad5138c12c7e1fe320630d36ffc74a34">Fresh Del Monte Produce Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) is a fully independent, publicly traded company with no financial or operational affiliation with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.delmonte.com%2F&amp;esheet=54285663&amp;newsitemid=20250703233115&amp;lan=en-US&amp;anchor=Del+Monte+Foods+Inc&amp;index=2&amp;md5=f32a7c7aa4a23ad5f1311b46c9325be9">Del Monte Foods Inc</a>., a separate entity currently involved in litigation and bankruptcy proceedings.
The two companies are entirely separate entities, with no shared ownership, governance, or operations. Del Monte Foods Inc. is a privately held U.S. company owned by a parent organization based in Singapore. Fresh Del Monte Produce Inc.'s financial or operational performance is not impacted by that separate, unaffiliated company's announced legal or financial proceedings.
While both businesses share rights to the Del Monte&#xAE; name through historical licensing arrangements, they operate under distinct ownership and serve different geographic markets.
Fresh Del Monte continues to operate with full stability and focus. The company remains financially strong, strategically aligned, and committed to delivering long-term value. It will report second quarter 2025 results during its scheduled earnings call on Wednesday, July 30, 2025.
Fresh Del Monte is a global leader in fresh and fresh-cut produce:
<ul>
<li>Headquartered in Coral Gables, FL, with operations in over 90 countries.</li>
<li>The global leader in pineapple innovation.</li>
<li>Owner of the Del Monte&#xAE; brand for prepared food products in Europe, Africa, and the Middle East.</li>
<li>Del Monte Foods Inc. — a different company with no affiliation to Fresh Del Monte — holds the rights to the Del Monte&#xAE; brand for prepared food products in the U.S. It does not have rights to fresh or fresh-cut fruit.</li>
</ul>
Customers, suppliers, and partners can remain confident in the continuity of Fresh Del Monte's operations and its commitment to delivering high-quality, Del Monte&#xAE;-branded products, services, and trusted support.

Fresh Del Monte Produce Clarifies It Is Not Affiliated With Del Monte Foods Inc.; Fresh Del Monte Says It Is Unaffected By Recent Litigation, Chapter 11 Proceedings Of Del Monte Foods

Waste Management's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) short percent of float has risen 8.43% since its last report. The company recently reported that it has 3.61 million shares sold short, which is 0.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Waste Management Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751558431_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Waste Management has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Waste Management's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Waste Management's peer group average for short interest as a percentage of float is 6.83%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About Waste Management?

Ecolab's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) short percent of float has fallen 12.0% since its last report. The company recently reported that it has 2.20 million shares sold short, which is 0.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ecolab Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751558425_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ecolab has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ecolab's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ecolab's peer group average for short interest as a percentage of float is 4.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Ecolab's Recent Short Interest

Madison Square Garden's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGE#NYSE">MSGE</a>) short percent of float has fallen 9.67% since its last report. The company recently reported that it has 1.31 million shares sold short, which is 4.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Madison Square Garden Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751558420_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Madison Square Garden has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Madison Square Garden's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Madison Square Garden's peer group average for short interest as a percentage of float is 8.83%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MSGE

What Does the Market Think About Madison Square Garden?

Live On CNBC, Treasury Secretary Scott Bessent, On Jobs Data, Says Any One Month Can Be Noisy, Overall Trend Is Good; Expect Acceleration In Private Sector Investment After Passage Of Tax And Spending Bill; It Is Up To Fed To Decide Rates; If Federal Reserve Doesn't Cut, Perhaps Interest Rate Cut In September Will Be Bigger

<a href="https://video.uni-frankfurt.de/Mediasite/Channel/98ddc3c0a08b4a5a9d5be127e45e6d1e5f/watch/8bee9e206b354104b173e6a2326d9cd21d">https://video.uni-frankfurt.de/Mediasite/Channel/98ddc3c0a08b4a5a9d5be127e45e6d1e5f/watch/8bee9e206b354104b173e6a2326d9cd21d</a>

Macro Notification

Fed's Bostic Says Fed Must Be More Explicit In How It Discusses Its Jobs Mandate

Global

Live On CNBC, Treasury Secretary Scott Bessent Says Japan Has A Lot Of Domestic Constraints Given Upper House Election On July 20

In a high-stakes maneuver that could reshape the oncology landscape, AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) is reportedly in talks with Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) about a partnership worth <a href="https://www.benzinga.com/general/biotech">up to $15 billion.</a>
<h2 class="wp-block-heading">What Does This Mean?</h2>
The deal would give AstraZeneca the rights to a lung cancer <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">drug called ivonescimab</a>.
Bloomberg reported that the discussions are <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-03/summit-is-said-in-talks-for-15-billion-partnership-with-astra" rel="noreferrer noopener">private</a>, citing sources familiar with the matter. Summit has also been in talks with other large pharmaceutical companies about the same drug.
Also Read: <a href="https://www.benzinga.com/news/health-care/25/05/45693375/summit-therapeutics-closely-watched-lung-cancer-study-of-ivonescimab-misses-overall-survival-endpoint" target="_blank" rel="noreferrer noopener">Summit Therapeutics&#8217; Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint</a>
Summit gained traction when, in September 2024, it released data from the primary analysis of the Phase 3 HARMONi-2 trial of ivonescimab conducted in China, sponsored by collaboration partner Akeso, Inc.
Ivonescimab <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40771038/summit-therapeutics-lung-cancer-candidate-surpasses-mercks-multi-billion-dollar-keytruda-cuts-ris" rel="noreferrer noopener">slashed the risk of disease progression</a> or death by 49% compared with Merck &amp; Co Inc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) Keytruda.
<h2 class="wp-block-heading">A Game-Changer Emerges</h2>
Cantor Fitzgerald initiated coverage on Summit in March, <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44463128/analyst-initiates-coverage-on-undervalued-summit-therapeutics" rel="noreferrer noopener">citing shares as undervalued</a>.
Then, in April, Summit Therapeutics&#8217; partner, Akeso, released topline data from the <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44963467/why-is-summit-therapeutics-stock-soaring-on-wednesday" rel="noreferrer noopener">Phase 3 HARMONi-6/K112-306 trial</a>.
Ivonescimab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in PFS compared to BeiGene, Ltd&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) Tevimbra (tislelizumab) plus chemotherapy.
According to Bloomberg, Summit has a market value of $17.4 billion and is mostly owned by its <a target="_blank" href="https://www.benzinga.com/news/24/10/41509307/billionaire-bob-duggan-snags-33m-miami-penthouse-amid-summit-therapeutics-689-stock-rally" rel="noreferrer noopener">Chairman and Co-CEO</a>, Bob Duggan, who holds nearly 75% of the company.
<h2 class="wp-block-heading">Duggan&#8217;s Winning Strategy</h2>
In 2015, Duggan was the CEO of Pharmacyclics Inc., which he sold to AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) for $21 billion. Bloomberg News reported that Duggan personally earned over $3 billion from that deal.
In June, Bristol-Myers Squibb Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) inked a similar licensing pact with Summit&#8217;s close rival, BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)
The $11 billion pact focuses on BioNTech's investigational bispecific antibody, BNT327, across various <a href="https://www.benzinga.com/news/health-care/25/06/45723383/bristol-myers-inks-11-billion-licensing-pact-with-biontech-for-bispecific-cancer-drug" target="_blank" rel="noreferrer noopener">solid tumor types</a>.
Price Action: Summit Therapeutics shares were up 8.49% at $24.54, while AstraZeneca shares were down 1.93% at $69.76 at the time of publication on Thursday, <a href="https://pro.benzinga.com/dashboard">according to Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46248233/robinhood-stock-pulls-back-from-all-time-highs-whats-going-on" target="_blank" rel="noreferrer noopener">Robinhood Stock Pulls Back From All-Time Highs: What&#8217;s Going On?</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

Health Care

Rumors

Contracts

ABBV

BNTX

SMMT

AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment

Live On CNBC, Treasury Secretary Scott Bessent Says Understand Vietnam Trade Deal Is Finalized In Principle; Megabill is going to pass; Tariffs Could Lead To One-Time Price Bump; We Are Going To See More Trade Deals; Countries Should Be Careful, Their Rate Could Boomerang Back To April 2 Rate; We'll See What We Can Do With EU

Fed's Bostic Says Significant Risk That Upward Pressure On Prices Will Be Around For Some Time; Tariffs Have Not Been Set Quickly, Leaving Firms Uncertain What Final Rates Will Be And Waiting To Make Pricing Decisions

Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) has outperformed the market over the past 15 years by 1.76% on an annualized basis producing an average annual return of 14.19%. Currently, Check Point Software has a market capitalization of $24.13 billion. 
Buying $100 In CHKP: If an investor had bought $100 of CHKP stock 15 years ago, it would be worth $740.92 today based on a price of $219.39 for CHKP at the time of writing.
<h3>Check Point Software's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751558010_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHKP

Here's How Much $100 Invested In Check Point Software 15 Years Ago Would Be Worth Today

<a href="https://x.com/Bakkt/status/1940798219812065740" title="https://x.com/Bakkt/status/1940798219812065740">https://x.com/Bakkt/status/1940798219812065740</a>

Bakkt Holdings, Inc. Class A Common Stock

BKKT

Bakkt Posts On X "Ethereum is evolving. We're ready for what's next. Bakkt will be on the ground at ETHGlobal Cannes. We're excited for a great week of discussion and insights on the future of on-chain finance, identity, and infrastructure."

<a href="https://asia.nikkei.com/Politics/International-relations/Rubio-postpones-Japan-South-Korean-trip-to-focus-on-Mideast-conflict" title="https://asia.nikkei.com/Politics/International-relations/Rubio-postpones-Japan-South-Korean-trip-to-focus-on-Mideast-conflict">https://asia.nikkei.com/Politics/International-relations/Rubio-postpones-Japan-South-Korean-trip-to-focus-on-Mideast-conflict</a>

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

'Rubio Postpones Japan, South Korean Trip To Focus On Mideast Conflict; U.S. Secretary Of State To Meet With Netanyahu In Washington On Monday' - Nikkei Asia

Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) has recently seen a positive stock performance trend, driven by strong aerospace demand and improved operational efficiency.
Howmet Aerospace shares climbed this week, rebounding from a brief pullback. The stock jumped more than 4% on June 27 and, after a minor dip on July 1, is hovering between $184 and $186.
Wall Street sentiment continues to favor Howmet. RBC Capital reiterated its Outperform <a target="_blank" href="https://www.benzinga.com/quote/HWM/analyst-ratings" rel="noreferrer noopener">rating</a> and raised its price forecast to $200. Truist Securities also reaffirmed its Buy rating, lifting its forecast to $192, citing strong aerospace demand and improved operational efficiency.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/46068345" rel="noreferrer noopener">BlackRock Bets Big On Defense Companies Amid Escalating Geopolitical Tensions: Palantir, Lockheed Martin, Northrop Grumman Among Stocks In Focus</a>
In late June, Howmet awarded CEO John C. Plant a $45 million <a href="https://www.benzinga.com/secfilings/25/06/46154214/howmet-aerospace-inc-general-corporate-statement-form8" target="_blank" rel="noreferrer noopener">retention grant</a> in restricted stock units (RSUs), set to vest in 2028. A related Form 4 filing disclosed that Plant received 255,363 RSUs. His base salary of $1.8 million and bonus eligibility remain unchanged under the amended agreement.
In the <a href="https://www.benzinga.com/news/earnings/25/05/45139061/howmet-aerospace-confident-of-passing-tariff-costs-to-customers-stock-takes-off" target="_blank" rel="noreferrer noopener">first quarter</a>, Howmet posted revenue of $1.94 billion, up 6.5% year over year. Adjusted earnings per share surged 51% to 86 cents, surpassing Wall Street estimates.
The company raised its full-year 2025 revenue outlook to between $7.88 billion and $8.18 billion &nbsp;(prior $7.93 $billion-$8.13 billion), above the $8.07 billion consensus. EPS guidance was also boosted to a range of $3.36 to $3.44 (prior $3.13-$3.21) ahead of the $3.27 average estimate.
The company is scheduled to report second-quarter results on July 29. Analysts forecast revenue of $1.98 billion-$2.00 billion versus the consensus of $2.00 billion, and EPS expected between $0.85 and $0.87 versus the consensus of $0.80.
Howmet shares have a 52-week range of $76.99 to $187.51. After falling nearly 39% from their February highs to April lows, the stock rebounded more than 30% in the past three months. Year-to-date, it&#8217;s up approximately 64% and is trading about 6.5% above its 50-day simple moving average.
Other aerospace names, including RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) and General Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), have seen similar momentum amid strong sector demand. For broader exposure, investors may consider the iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) and the Gabelli Commercial Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCAD#NYSE">GCAD</a>).
Price Action: HWM shares were trading higher by 3.08% to $177.93 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/46246152" target="_blank" rel="noreferrer noopener">iPhone Sales Bounce Back In China, But Huawei And Xiaomi Intensify Pressure</a></li>
</ul>
Photo by T. Schneider via Shutterstock

Movers

GCAD

iShares Dow Jones US Aerospace & Defense Index Fund

What's Going On With Howmet Aerospace Stock?

When a loved one passes away, navigating <a href="https://www.benzinga.com/personal-finance/management/25/06/46017701/its-not-a-ponzi-scheme-its-a-social-contract-sen-chuck-grassley-defends-and-urges-reform-for-social-security">Social Security</a> can be difficult. But for one New York widow, delays in getting a death certificate led to more than just paperwork problems — it caused her Social Security and health insurance to be cut off while she was undergoing cancer treatment.
<h2 class="wp-block-heading">A Marriage Long in the Past, But Still on Record</h2>
The widow, whose story was shared on Reddit's <a href="https://www.reddit.com/r/SocialSecurity/comments/1lhzxe1/widow_mother_benefits_being_terminated_due_to/">r/SocialSecurity forum</a>, was legally married decades ago to a man she hadn't seen or spoken to in over 30 years. Although they had gone their separate ways, they never divorced — a detail that would later complicate her situation.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
She had already been receiving Social Security and health insurance benefits. But when the <a href="https://www.benzinga.com/general/health-care/25/05/45222153/social-security-halves-overpayment-clawbacks-after-outcry-but-advocates-say-50-cut-still-stings">Social Security Administration</a> learned that her estranged husband had passed away in Connecticut, it flagged her record. Because she was still legally married to him, SSA categorized her as a widow — and required proof of his death to continue her benefits.
To stay eligible, she needed to submit a copy of his death certificate. But since she had no contact with his family and limited information about the circumstances of his death, she had to request the certificate through Connecticut's online system. The problem? Processing can take anywhere from 30 to 120 days — or even longer.
<h2 class="wp-block-heading">Social Security: Benefits Pending Proof</h2>
According to the <a href="https://www.ssa.gov/pubs/EN-05-10084.pdf">SSA</a>, survivors' benefits can be adjusted automatically if the agency already has the necessary information. But if they don't — and especially if the deceased's death certificate isn&#8217;t on file — benefits may be delayed or withheld.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
The SSA typically requires a death certificate to update a person's marital status and determine eligibility for benefits. In this case, while the widow waited for the document to arrive, Social Security warned that her health insurance and monthly check would be cut off if she didn't provide timely proof.
She visited her local SSA office and was told verbally that her benefits would continue. However, no written confirmation followed — and shortly after, she received a letter stating her benefits were being terminated.
<h2 class="wp-block-heading">Commenters Share Tips — and Frustration</h2>
In response to the Reddit post, several commenters weighed in. One person suggested contacting the funeral home that handled the deceased&#8217;s arrangements, as they may have faster access to the death certificate. Another recommended calling the county in Connecticut where he passed away, noting that as a legal widow, she's entitled to obtain the record.
Some readers expressed disbelief, noting that in their own experiences, survivors' benefits had been adjusted automatically without taking any action. But not all cases follow the same path, especially when prior communication with the deceased or their family isn't possible.
See Also: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
<h2 class="wp-block-heading">What Can Others Learn From This?</h2>
This situation highlights how delays in documentation can lead to serious disruptions — even when eligibility isn't in question. For those relying on <a href="https://www.benzinga.com/personal-finance/management/25/06/46056038/still-working-at-69-eligible-for-social-security-should-he-keep-waiting-or-claim-now">Social Security income</a> and Medicare coverage, losing access, even temporarily, can cause harm, particularly when ongoing medical treatment is involved.
If you&#8217;re in a similar situation, the SSA encourages contacting your local office or visiting <a href="http://ssa.gov/">SSA.gov</a> to understand what documents you need and how to appeal decisions if necessary. Survivors also have the right to challenge decisions if benefits are denied or cut off.
For widows and widowers, keeping copies of old marriage certificates and knowing how to obtain key documents in advance may help prevent similar disruptions in the future.
Read Next: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Image: Shutterstock

Widow's Social Security And Health Insurance Cut Off — All Because A Death Certificate Took Too Long

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with Samda Biolab Co., Ltd. and INNOCS AI, aimed at advancing a novel blood-based diagnostic kit for early detection of pancreatic cancer.
&nbsp;
Liminatus Pharma recognizes the groundbreaking potential of the CA19-9-combined INNOCS diagnostic platform jointly developed by Samda and INNOCS AI, and has resolved to actively participate in the R&amp;D consortium with a view to enhancing corporate value and accelerating entry into the precision oncology diagnostics market.
&nbsp;
The INNOCS platform—powered by a deep learning algorithm and a panel of 16 metabolomic biomarkers—demonstrates remarkable performance when paired with CA19-9. According to recent clinical data from a cohort of 1,086 subjects (393 pancreatic cancer patients and 693 control subjects), the combined diagnostic approach demonstrated a sensitivity of over 95% and specificity exceeding 99%, including detection of CA19-9-negative pancreatic tumors.
&nbsp;
Liminatus Pharma is committed to contributing clinical development expertise and regulatory guidance as part of the consortium. Upon entering the commercialization phase, Liminatus Pharma will lead the regulatory approval process through both the U.S. Food and Drug Administration (FDA) and the Korean Ministry of Food and Drug Safety (KMFDS).
&nbsp;
By participating in this consortium, Liminatus Pharma will proactively oversee the acquisition of larger clinical datasets essential for regulatory submissions. Prior to the initiation of FDA filing, Liminatus Pharma intends to complete internal approval processes to support a definitive agreement encompassing investment, commercialization, and go-to-market strategy.
&nbsp;
If successfully commercialized, this blood-based diagnostic kit could generate substantial economic value. The global pancreatic cancer diagnostics market is projected to reach $3 billion by 2026, with the blood-based diagnostics segment expected to surpass $700 million and the high-risk population screening segment estimated at over $100 million. As clinical guidelines shift to embrace multi-marker strategies, early entry into this space offers Liminatus Pharma a pivotal opportunity for market leadership in metabolomics-driven cancer diagnostics.
&nbsp;
Liminatus Pharma views this strategic partnership as a critical milestone in its broader mission to transform cancer care through next-generation precision diagnostics. By leveraging the complementary strengths of INNOCS AI's artificial intelligence technology, Samda's biomarker platform, and Liminatus Pharma's regulatory and commercial infrastructure, the consortium is poised to deliver meaningful innovation in one of oncology's most challenging frontiers.
&nbsp;

LIMN

Liminatus Pharma Enters MOU With Samda Biolab And INNOCS AI To Advance CA19-9-Combined INNOCS Diagnostic Platform For Early Pancreatic Cancer Detection

WIIM

Summit shares are trading higher after Bloomberg reported the company is in talks for a $15 billion partnership with AstraZeneca.

Morgan Stanley analyst Betsy Graseck maintains U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) with a Overweight and raises the price target from $50 to $51.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on U.S. Bancorp, Raises Price Target to $51

Press Releases

Webuy Global Ltd Recognized as One of Singapore's Fastest-Growing Companies 2025

Webuy Global Ltd. Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Rule

Webuy Global Ltd. Provides Update on Nasdaq Listing and Strategic Growth Initiatives

Earnings

Webuy Global Ltd. Reports FY2024 Results and Achieves First-Ever Quarterly Profit

Webuy Global Ltd. (Nasdaq: WBUY) Reinstated Listing on Nasdaq Capital Market and Returns to Profitability with Strong First Quarter Growth in Travel

Webuy Global Ltd. Appoints Award-Winning Corporate Leader Heng Wee Koon as Independent Director

Webuy Global Ltd. Named One of Asia-Pacific's Fastest-Growing Companies by Financial Times

Webuy Global Ltd. and CTG MICE Service Company Limited., a Subsidiary of China Tourism Group, Sign Landmark Agreement to Boost Inbound Tourism to China

Webuy Global Ltd Integrates Coinbase to Accept Stablecoin Payments - Leading the Way in Travel Technology and Digital Payments

Synergy CHC Corp. (NASDAQ: SNYR) Secures Distribution Wins for FOCUSfactor® Supplements and Functional Beverages – More Stocks Inside

AMZN

ARTL

BMNR

COST

IPDN

PLUG

PNPNF

SNYR

TSXV:PNPN

WBUY

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Chanson International Holding - Class A Ordinary Shares

Chanson International

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Comments

Webuy Global

Vendite allo scoperto

Webuy Global (NASDAQ:WBUY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO